The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Elevation Oncology Inc(NASDAQ:ELEV) 
Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. The company's lead candidate is EO-3021, an antibody-drug conjugate designed to target Claudin 18.2, a cl...
Elevation Oncology Number of Twitter Followers
Elevation Oncology Days Payable Outstanding ttm (DPO)
Elevation Oncology Op Cashflow Per Share ttm
Elevation Oncology Free Cashflow Per Share ttm
Elevation Oncology Cash Per Share ttm
Elevation Oncology (GAAP) P/E ratio ttm
Elevation Oncology P/B ratio ttm
No extra charts and metrics for this ticker.